consumer health

Haleon to invest Rs 2,000 crore in first manufacturing plant in India and South Asia

Haleon, the UK consumer health firm formerly part of GSK, will invest about Rs 2,000 crore (£175 million) to build its first manufacturing facility in India and South Asia. The greenfield plant in Pithampur, Madhya Pradesh, is expected to come up over the next two to three years, supporting local production of brands like Sensodyne, Crocin and Eno as the company reduces reliance on contract manufacturers.